Clinical Efficacy of Tumor Antigen-Pulsed DC Treatment for High-Grade Glioma Patients: Evidence from a Meta-Analysis
Figure 3
Comparison of 0.5-, 1-, 1.5-, and 2-year progression-free survival (PFS) between the non-DC and DC groups (A); Forest plot for 3-, 4-, and 5-year PFS between the non-DC and DC groups in HGG patients (B).
The fixed effects meta-analysis model (Mantel-Haenszel method) was used in this analysis.